- ►diabetesjournals.org NN Zammitt, BM Frier - Diabetes Care, 2005 - Am Diabetes Assoc The importance of strict glycemic control to limit the risk of diabetic vascular
complications is indisputable, but many barriers obstruct its attainment.
Hypoglycemia is recognized to be a major limitation in achieving good ... Cited by 89 - Related articles - All 6 versions
- ►sediabetes.org [PDF] K Jeitler, K Horvath, A Berghold, TW Gratzer, … - Diabetologia, 2008 - Springer Abstract Aims We compared the effects of continuous subcutaneous insulin
infusion (CSII) with those of multiple daily insulin (MDI) injections on
glycaemic control, risk of hypoglycae- mic episodes, insulin requirements ... Cited by 32 - Related articles - BL Direct - All 5 versions
- Free from Publisher J Rosenstock, AJ Ahmann, G Colon, J Scism- … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—Baseline A1C was similar (PPT 8.8%; BBT 8.9%; P = 0.598). At week 24,
A1C was lower with BBT (6.78 vs. 6.95%, P = 0.021). A1C was reduced
significantly from baseline for both therapies (P < 0.0001). The difference ... Cited by 29 - Related articles - BL Direct - All 5 versions
M Malone - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books STUDY SELECTION AND DATA EXTRACTION : Changes in weight are generally reported
as a primary or secondary outcome of many studies. Where possible, prospective,
randomized, controlled trials were preferred; however, many studies were ... Cited by 23 - Related articles - BL Direct - All 6 versions
- Free from Publisher JC Pickup, E Renard - Diabetes Care, 2008 - Am Diabetes Assoc Insulin pump therapy (continuous subcutaneous insulin infusion [CSII]) is now an
established form of intensive insulin treatment. It is pertinent to ask,
however, if multiple daily injection (MDI) regimens based on new ... Cited by 18 - Related articles - BL Direct - All 5 versions
DC Klonoff - J Diabetes Sci Technol, 2007 - journalofdst.org An artificial pancreas is a closed-loop system containing only synthetic
materials which substitutes for an endocrine pancreas. No artificial pancreas
system is currently approved; however, devices that could become components ... Cited by 15 - Related articles - View as HTML - All 3 versions
S Chatterjee, JR Tringham, MJ Davies - Expert Opin. Pharmacother., 2006 - informahealthcare.com Insulin treatment in Type 1 and Type 2 diabetes has come a long way since its
discovery by Banting and Best in 1922. Early insulin therapy was life-saving,
but was associated with practical problems and had side effects such as ... Cited by 14 - Related articles - BL Direct - All 5 versions
P Rossetti, F Porcellati, GB Bolli, CG Fanelli - Diabetes Care, 2008 - Am Diabetes Assoc Insulin therapy in diabetes, both at onset and after several years' duration, is
primarily directed to maintain near-normoglycemia to prevent the onset and/or
delay progression of long-term complications (1,2). However, it is ... Cited by 13 - Related articles - BL Direct - All 4 versions
LB Haas - Journal of the American Medical Directors Association, 2007 - Elsevier Approximately 25% of patients in nursing homes have diabetes, and it is the
primary reason for 12% of nursing home admissions among residents 45 to 75 years
of age. Glycemic control is important to reduce the risk of diabetic ... Cited by 13 - Related articles - All 12 versions
X Zhang, SL Norris, FM Chowdhury, EW … - Medical Care, 2007 - pdfs.journals.lww.com Health-related quality of life (HRQL) is increasingly used as an outcome measure
for interventions among people with chronic diseases1,2 for several reasons.
First, interven- tion studies have traditionally focused on symptomatic and ... Cited by 13 - Related articles - BL Direct - All 3 versions
